Pediatrix Medical Group Announces Leadership Changes
Ticker: MD · Form: 8-K · Filed: Jun 17, 2024 · CIK: 893949
Sentiment: neutral
Topics: leadership-change, board-election, executive-departure
TL;DR
Pediatrix CMO out, new CMO in, two new board members elected.
AI Summary
Pediatrix Medical Group, Inc. announced on June 17, 2024, the departure of its Chief Medical Officer, Dr. Mark L. Callahan, effective June 14, 2024. The company also announced the appointment of Dr. Jennifer L. Stone as the new Chief Medical Officer, effective June 17, 2024. Additionally, the company reported the election of two new directors, Ms. Pamela G. Bentley and Mr. David L. Osborne, to its Board of Directors.
Why It Matters
Changes in key executive and board positions can signal shifts in company strategy or operational focus, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Leadership changes, especially at the CMO level, can introduce uncertainty regarding strategic direction and operational execution.
Key Players & Entities
- Pediatrix Medical Group, Inc. (company) — Registrant
- Dr. Mark L. Callahan (person) — Departing Chief Medical Officer
- June 14, 2024 (date) — Effective date of Dr. Callahan's departure
- Dr. Jennifer L. Stone (person) — Appointed Chief Medical Officer
- June 17, 2024 (date) — Effective date of Dr. Stone's appointment
- Ms. Pamela G. Bentley (person) — Elected Director
- Mr. David L. Osborne (person) — Elected Director
FAQ
Who has been appointed as the new Chief Medical Officer for Pediatrix Medical Group?
Dr. Jennifer L. Stone has been appointed as the new Chief Medical Officer, effective June 17, 2024.
When did Dr. Mark L. Callahan's departure as Chief Medical Officer become effective?
Dr. Mark L. Callahan's departure as Chief Medical Officer was effective June 14, 2024.
How many new directors were elected to the Board of Directors?
Two new directors, Ms. Pamela G. Bentley and Mr. David L. Osborne, were elected to the Board of Directors.
What is the company's principal executive office address?
The company's principal executive office is located at 1301 Concord Terrace, Sunrise, Florida, 33323.
What is the Commission File Number for Pediatrix Medical Group?
The Commission File Number for Pediatrix Medical Group is 001-12111.
Filing Stats: 477 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-06-17 16:30:12
Filing Documents
- md-20240617.htm (8-K) — 35KB
- img260269858_0.jpg (GRAPHIC) — 309KB
- 0000950170-24-074283.txt ( ) — 907KB
- md-20240617.xsd (EX-101.SCH) — 23KB
- md-20240617_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Pediatrix Medical Group, Inc. Date: June 17, 2024 By: /s/ C. Marc Richards C. Marc Richards Chief Financial Officer